Title : Hyperglycemia potentiates the proatherogenic effects of C-reactive protein: reversal with rosiglitazone.

Pub. Date : 2003 Apr

PMID : 12689821






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Hyperglycemia potentiates the proatherogenic effects of C-reactive protein: reversal with rosiglitazone. Rosiglitazone C-reactive protein Homo sapiens
2 Importantly, the PPARgamma agonist, rosiglitazone, attenuated the proatherogenic effects of CRP under both basal and hyperglycemic conditions. Rosiglitazone C-reactive protein Homo sapiens
3 The direct proatherogenic actions of CRP are exaggerated in the hyperglycemic milieu, and attenuated by rosiglitazone. Rosiglitazone C-reactive protein Homo sapiens